» Authors » Stephan J Ott

Stephan J Ott

Explore the profile of Stephan J Ott including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 2150
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Luedde M, Winkler T, Heinsen F, Ruhlemann M, Spehlmann M, Bajrovic A, et al.
ESC Heart Fail . 2017 Aug; 4(3):282-290. PMID: 28772054
Aims: In spite of current medical treatment approaches, mortality of chronic heart failure (HF) remains high and novel treatment modalities are thus urgently needed. A recent theory proposes a possible...
2.
Ott S, Waetzig G, Rehman A, Moltzau-Anderson J, Bharti R, Grasis J, et al.
Gastroenterology . 2016 Nov; 152(4):799-811.e7. PMID: 27866880
Background & Aims: Fecal microbiota transplantation (FMT) is a highly effective therapy for recurrent Clostridium difficile infection (CDI). However, transferring undefined living bacteria entails uncontrollable risks for infectious and metabolic...
3.
Heinsen F, Knecht H, Neulinger S, Schmitz R, Knecht C, Kuhbacher T, et al.
Gut Microbes . 2015 Jul; 6(4):243-54. PMID: 26178862
Gut microbiota play a key role in the host's health system. Broad antibiotic therapy is known to disrupt the microbial balance affecting pathogenic as well as host-associated microbes. The aim...
4.
Perez-Cobas A, Artacho A, Ott S, Moya A, Gosalbes M, Latorre A
Front Microbiol . 2014 Oct; 5:335. PMID: 25309515
Antibiotic therapy is a causative agent of severe disturbances in microbial communities. In healthy individuals, the gut microbiota prevents infection by harmful microorganisms through direct inhibition (releasing antimicrobial compounds), competition,...
5.
Knecht H, Neulinger S, Heinsen F, Knecht C, Schilhabel A, Schmitz R, et al.
PLoS One . 2014 Mar; 9(2):e89417. PMID: 24586762
Clostridium difficile infections are an emerging health problem in the modern hospital environment. Severe alterations of the gut microbiome with loss of resistance to colonization against C. difficile are thought...
6.
Ferrer M, Martins Dos Santos V, Ott S, Moya A
Gut Microbes . 2014 Jan; 5(1):64-70. PMID: 24418972
It is known that the gastrointestinal tract (GIT) microbiota responds to different antibiotics in different ways and that while some antibiotics do not induce disturbances of the community, others drastically...
7.
Arlt A, Bharti R, Ilves I, Hasler R, Miettinen P, Paajanen H, et al.
Innate Immun . 2013 Dec; 21(1):30-41. PMID: 24336024
Appendicitis represents a common and severe gastrointestinal illness in younger individuals worldwide. The disease is characterized by an excessive inflammatory response and it is believed that bacterial overgrowth due to...
8.
Perez-Cobas A, Artacho A, Knecht H, Ferrus M, Friedrichs A, Ott S, et al.
PLoS One . 2013 Nov; 8(11):e80201. PMID: 24282523
The human intestinal microbiota performs many essential functions for the host. Antimicrobial agents, such as antibiotics (AB), are also known to disturb microbial community equilibrium, thereby having an impact on...
9.
Hernandez E, Bargiela R, Suarez Diez M, Friedrichs A, Perez-Cobas A, Gosalbes M, et al.
Gut Microbes . 2013 Jun; 4(4):306-15. PMID: 23782552
The microbiomes in the gastrointestinal tract (GIT) of individuals receiving antibiotics and those in obese subjects undergo compositional shifts, the metabolic effects and linkages of which are not clearly understood....
10.
Biedermann L, Zeitz J, Mwinyi J, Sutter-Minder E, Rehman A, Ott S, et al.
PLoS One . 2013 Mar; 8(3):e59260. PMID: 23516617
Background: The human intestinal microbiota is a crucial factor in the pathogenesis of various diseases, such as metabolic syndrome or inflammatory bowel disease (IBD). Yet, knowledge about the role of...